Market Tracker

10/20 8:48am ET

Theravance Inc (NASDAQ:THRX)

17.27
Data as of Oct 17
 -1.11 / -6.04%
Today’s Change
15.76
Today|||52-Week Range
32.88
-39.86%
Year-to-Date

Today’s Trading

Previous close18.38
Today’s open18.76
Day’s range-- - --
Volume1,135,108
Average volume (3 months)835,505
Market cap$2.0B
Dividend yield5.79%
Data as of 10/17/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+35.93%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book6.44

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.29-1.09%
AVNRAvanir Pharmaceutica...-0.24-2.15%
RCPTReceptos Inc+3.20+5.24%
IRWDIronwood Pharmaceuti...-0.33-2.56%
Data as of 10/17/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts